Phospho-ERK1/ERK2 (T202/185) Antibody

About the Target

Phospho-ERK1/ERK2 (T202/185) is a target of interest in many antibody-based workflows. Phospho-ERK1 and ERK2 (Thr202/185) are activated forms of the protein-serine/threonine kinases ERK1 and ERK2, key components of the Ras-Raf-MEK-ERK signaling pathway. These kinases are crucial for regulating a wide range of cellular processes including cell proliferation, survival, migration, differentiation, and transcription. ERK1 and ERK2 share structural similarities, with molecular weights of approximately 44 kDa (ERK1) and 42 kDa (ERK2), and consist of N-terminal regulatory regions, a central kinase domain responsible for catalytic activity, and a C-terminal domain that facilitates substrate interaction. Depending on the literature source, Phospho-ERK1/ERK2 (T202/185) may also be discussed as Phospho-ERK1/ERK2 (T202/185).

Reported cellular context includes cell junction, cytoplasm, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following Phospho-ERK1/ERK2 (T202/185) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

Phospho-ERK1/ERK2 (T202/185) is commonly interpreted in the context of cancer, neuroscience, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell junction, cytoplasm, and membrane across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-ERK1/ERK2 (T202/185). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-ERK1/ERK2 (T202/185) reflect biology rather than handling. When interpreting Phospho-ERK1/ERK2 (T202/185), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Phospho-ERK1/ERK2 (T202/185) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.